Table 5.
Association between treatment group and overall mortality.
| Model | Surgery vs. RT and surgery (Adjuvant treatment group | Non-RT and non-surgery vs. RT (Palliative treatment group) | ||
|---|---|---|---|---|
| HR (95% CI) | p-value | HR (95% CI) | p-value | |
| Propensity score adjusted* | 0.80 (0.73–0.87) | <0.001 | 0.81 (0.70–0.94) | 0.007 |
| Propensity score matched | 0.74 (0.66–0.81) | <0.001 | 0.78 (0.64–0.95) | 0.012 |
| SMRW | 0.74 (0.69–0.80) | <0.001 | 0.79 (0.69–0.92) | 0.002 |
| OW | 0.79 (0.69–0.89) | <0.001 | 0.79 (0.64–0.97) | 0.028 |
| Multivariate adjusted after PSM* | 0.71 (0.64–0.78) | <0.001 | 0.75 (0.61–0.92) | 0.005 |
RT, radiotherapy; HR, hazard ratio; CI, confidence interval; SMRW, standardized mortality ratio weighting; OW, overlap weighting; PSM, propensity score matching.
Cox proportional hazards model comparing the quartiles in different models to determine whether the overall HR is a true representation of the effects of adjuvant RT and palliative RT.
*Adjusted age, sex, year of diagnosis, marital status, race, stage, grade, tumor size, and chemotherapy status after propensity score matching.